Menu

Bird Brains Have Numerous Neurons

Many avian species have more neurons than do mammals with similar-mass brains.

Jun 14, 2016
Tanya Lewis

African grey parrotWIKIMEDIA, PAPOOGAA team of researchers dissected the brains of 28 bird species, finding that the animals have more neurons packed into their pallial telencephalons—a brain region involved in high-level learning—than do mammals with brains of similar mass. Parrots have between 227 million and 3.14 billion such neurons, while songbirds have between 136 million and 2.17 billion, according to the study published yesterday (June 13) in PNAS. By mass, that amounts to twice as many neurons as found in monkey brains, and four times as many as in rodent brains.

“This pretty much answers the question we began with: How can these birds be so clever with such small brains?” study coauthor Pavel Nemec of Charles University in Prague told The Guardian. “The answer is that there are so many neurons, their computing power is comparable to that of primates.”

To count the brain cells in each bird specimen, Nemec and colleagues dissected the animals’ brains and dissolved them in a detergent to make a mixture one researcher called “brain soup,” according to Science. The researchers focused on the pallial telencephalon because the region is involved in behaviors such as tool use and birdsong.

The bird neurons were much smaller and more densely packed than those in mammalian brains. This may allow the birds to be lighter for flight, the researchers wrote in their paper.

“These new findings could definitely help to explain why some birds, such as jays, crows and ravens, excel in their cognitive skills,” Andreas Nieder of the University of Tübingen in Germany, who was not involved in the work, told The Guardian.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.